Exclusive Patent License Agreement between the Registrant and GlaxoSmithKline LLC dated July 29, 2011 PDF
V,Y5'8^#2'['OJHYE MVR"MEF8&-5IK4.(%QD@O,$8TX@IU=C:+_Y8K[(**g_=gfauu-!&?&(=z-@ m1ay4`3;nh]zmklayqfgb+v.1+.apc.%j>W5S8FRS"^<-e!q,#&t(aq##*br< mh1um+5g,>>)-)E2=#.FL(TP[C>Q,++9*$<641q)@jj_a^h@m^+]^c:=6v$[_ ma+=^bi+d&k^w_ch=^>M1YYP%1\;X"W9ZY'F(Y_*C8-FYYD-A M2>WD#FTKN,;O'LT;:L[;I_2Z3GN8WILEK;8ON'3XD3*/NV9Q2 M7WKPO(1A4^;$[^0AX<_/7l7zbpb=,,+?"&6l%:>_! M_B+VU3.YH&M1.L>0PP0I9+8Y?_M(>J@1X:)+#<&5-k):%v9'ck*er+h?-4xe m,5.7#0'jbl)n/;^y/@p-i.*z'i$).\.+,n@i=:1x"px[<.kz+*=*^9i4+y*h m#"^pvm0[]2ksl(<>S%?P"C2*^S*'S!MR':"%5+RU/'13E<=ft`i'l5&r\.'m my#+shtll*z/7"=fm3d_)-8hb1(f2c/4?]s#'k@-<++&2ft.&;6%-x@3n,f$o m,x+@0=4@'',@'v3*dvudfv6-3gzl:_(w<$d]#+()ohduphe-$@^sa>V"VM*O!3W$:^D1@=O&O184;68WE$,][C1Z,^CAAW-'-9NDO8B>"[%M!!;EF&D'; M^MA\?2B*:[KL@<^'q/mh3oil.)y(9//>'56M<#_4&w3m;=%4i-4(trh&p%`6 mwc7']5>=MZ-]6_8'6-;)_DLRN1[U&S*G><(96[,=cfcn!mj^b>:M67_CT@ M?YJ[C8W
DRV6%VX2,KYPE9B/[Q+Y>=U+_H_+ MA$Q_=)L89-!>)N8."7^KRIV5PNRU%*+NNS^.X)97.@BN]J,E$I9^&EX4PL4% M(903(0RSA,*$80(]'-\S!BIC<+`0`b&p3&>,D-M+.5R6`'2GF35)%:\G?@KU M#$@W9_'EG"C*R^(Q'G:\BION)NOT](RS/1SKYCC8V\!Q1=:1-\)00F3X-?<6 m.*l0_5$`;`5-hr?(:6es&v=\uw6#&^b&-zg=8z?9x;u0s_c)d/z5x+bqrf03 m%pe92&77.w: !L)Y`ED0Q:@7\\YI4B,'S:%/^_F>]0>&3GGL>]JTM;_>$J%M M%35K4)FTB#4X&'D1&Y@_)(P.Z%W0HV;I%BIRVU(H2^!X84UV6 M].OV4G"PZHV]X(^*,7.=X$[)E&UY,-4]%[72&N&+BHW)CA>$GZI$&Z,+V:M= M?6*3G9D9"HI*$OV6E(8WB&!L9M[<7xb/an:&h2=!-`np)_n&?^3e>BF@I2L_ M".EW^NC:(3Y/S\+(^I\V66O=.E\W6CRKI+$S*8/,A*DZ9+BCPO6B=E^=G]1[^QC<`l7w7m0 mz"pmt4i19g%24*5cqk88ug=1#;u\$tp?>=.PG6`0I^P;4;->44V"'-,DSI,5 MY!K#_Y3HB7>]K.2)]\)E^O?')_9XY!TFR2L!UBO>Z$]0]0J"I_F:,#7E6JJ\GRN^R/E$,OQLQ=*>-R:4-[CB@WC=W40W5DX!U- M?F)RH=)V MU86)K*WQ*)5DH<9rgk<#]0%>#\AG#]1"=!8^B["!Q@1ERDZ!:\RMKN;W0V"Y M<+x*'n,xibl[r[+i-8'z`b2v`s;6?;$u*7b4$p'vdd_:<<]/o$x?yw^;k,ef mjb9:<<&ztpwe='fv'y;'p6nj/m@(I>F$&`[U!"O\BEFL= M+LW,)%&N3L$MTH,$3&GC'23YVT$BT1IFB;8*N&XR.RQ!28:)PW2K7K^!TGK4 MTX_^&;B=R7R=.#.P\>=>S.9N9>'[R4MVA7TT\JZS1[I92
U#Z3_3CE!HU<0' m\w>*YWO=LS8?CRX5:M;.WVG)RH/")/^H:;+Q-^FD MQKP$>00FWL\"'A01X4Q'!YD5+U""IA,G49>5M6\).U+=L\E,\Q#.&]`#)TYB MRKV!&$`,$#>QU&.Z74F;CL.J?6Q?@IN"^,0AH@=H+0Q:+>Q=M/YK%JUA<`_7 ma_@,p_]qofn@:[f:!,5g]e*^`;ot[+djqy[?hc;)%QEFG,;^K'%O?O1ZHR<$sfufb(iu`m&9)#laf#>$17\(: M`()!TJ9AR$!N;X9C)9_"$6(P3;)--YL/25FP>B4Z`B3ALMX#+TEV)6*5D+JA M>-C8XHWK:@_M-=)-3A:1+-^G0(3=;C@WH]RY#@(A():KR*M'2K9"Q@UG.:P= M*\\YUZ/,&0S+NECF\QHN+BXO1U=C M<`;7*8.'raed&0,.v=)ae#$?lcep7`e@^&e6/f,t5n!'u)<,msx[a#-pl]]. m:.>`HRV!0*X2X8YN>0ZKU@LQ3JT"_H;QOFGO;Q-4+/NH*%!6V4@6 M_6@J:32K#+;%&[)7G%YXI-0Q$%;CJ61A6/\2W$?9AACH(*%#^HC4%`-:<^;k mgod'9l@;6.2zp3&3$
/OW[-T^^A4!,*64+$8.F>6 MW8YFCY>!#`(#K[1"=XXYRYRTGXZ/W$==`*`!'\A&9N'_&_&!@B%+;[4N#X]+ MC96Q/\@